| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.877 | 0.001 | 0.877 | Glutamate decarboxylase inhibitor | 0.411 0.003 DBMET00549 0.14 0.015 DBMET00563 | ||
| 0.789 | 0.001 | 0.789 | Phenylalanine 4-hydroxylase inhibitor | 0.64 0.002 DBMET00549 0.27 0.004 DBMET00563 | ||
| 0.709 | 0.004 | 0.709 | Bronchodilator | 0.37 0.006 DBMET00549 0.224 0.015 DBMET00563 | ||
| 0.699 | 0.003 | 0.699 | Peroxidase inhibitor | 0.53 0.007 DBMET00549 0.565 0.005 DBMET00563 | ||
| 0.648 | 0.004 | 0.648 | Calcium channel L-type activator | 0.551 0.013 DBMET00549 0.408 0.076 DBMET00563 | ||
| 0.644 | 0.005 | 0.644 | Antiadrenergic | 0.22 0.021 DBMET00549 | ||
| 0.64 | 0.005 | 0.64 | Adrenaline antagonist | 0.217 0.02 DBMET00549 | ||
| 0.645 | 0.013 | 0.645 | Aldehyde oxidase inhibitor | 0.519 0.03 DBMET00563 | ||
| 0.626 | 0.023 | 0.626 | Cyclophilin D inhibitor | 0.599 0.028 DBMET00549 0.357 0.117 DBMET00563 | ||
| 0.581 | 0.015 | 0.699 | Spasmolytic | 0.452 0.03 DBMET00549 0.699 0.006 DBMET00563 | DBMET00563 | |
| 0.574 | 0.008 | 0.81 | Superoxide dismutase inhibitor | 0.701 0.004 DBMET00549 0.81 0.003 DBMET00563 | DBMET00563 | |
| 0.571 | 0.035 | 0.571 | Transcription factor NF kappa B inhibitor | 0.429 0.057 DBMET00549 0.514 0.042 DBMET00563 | ||
| 0.505 | 0.009 | 0.505 | Interleukin agonist | 0.21 0.111 DBMET00549 | ||
| 0.519 | 0.033 | 0.601 | Antiobesity | 0.601 0.02 DBMET00549 | DBMET00549 | |
| 0.496 | 0.028 | 0.496 | 5 Hydroxytryptamine release stimulant | |||
| 0.481 | 0.013 | 0.481 | Vasodilator | 0.249 0.07 DBMET00549 0.309 0.045 DBMET00563 | ||
| 0.493 | 0.031 | 0.601 | Histamine release inhibitor | 0.449 0.051 DBMET00549 0.601 0.01 DBMET00563 | DBMET00563 | |
| 0.461 | 0.006 | 0.461 | 5 Hydroxytryptamine uptake stimulant | 0.219 0.119 DBMET00549 0.207 0.139 DBMET00563 | ||
| 0.471 | 0.017 | 0.471 | Hypoxia-inducible factor 1 alpha inhibitor | 0.268 0.085 DBMET00549 0.411 0.027 DBMET00563 | ||
| 0.466 | 0.019 | 0.466 | Cardiotonic | |||
| 0.466 | 0.02 | 0.466 | Vasodilator, coronary | 0.237 0.147 DBMET00549 0.317 0.074 DBMET00563 | ||
| 0.483 | 0.038 | 0.483 | 5 Hydroxytryptamine release inhibitor | 0.297 0.169 DBMET00563 | ||
| 0.454 | 0.01 | 0.454 | Calcium channel activator | 0.304 0.088 DBMET00549 0.341 0.056 DBMET00563 | ||
| 0.441 | 0.005 | 0.441 | Tyrosine 3 hydroxylase inhibitor | 0.238 0.081 DBMET00549 0.216 0.109 DBMET00563 | ||
| 0.482 | 0.046 | 0.592 | Antibacterial | 0.592 0.02 DBMET00549 0.589 0.021 DBMET00563 | DBMET00549 | |
| 0.437 | 0.004 | 0.437 | GABA C receptor agonist | 0.121 0.049 DBMET00549 | ||
| 0.489 | 0.064 | 0.489 | Caspase 9 stimulant | 0.324 0.169 DBMET00563 | ||
| 0.463 | 0.039 | 0.663 | Cholesterol antagonist | 0.597 0.019 DBMET00549 0.663 0.011 DBMET00563 | DBMET00563 | |
| 0.418 | 0.006 | 0.418 | Peptidyltransferase inhibitor | 0.324 0.017 DBMET00549 0.273 0.037 DBMET00563 | ||
| 0.421 | 0.019 | 0.421 | Psychostimulant | |||
| 0.444 | 0.042 | 0.444 | Vasodilator, peripheral | 0.217 0.157 DBMET00563 | ||
| 0.387 | 0.004 | 0.387 | Alcohol oxidase inhibitor | |||
| 0.409 | 0.027 | 0.422 | Free radical scavenger | 0.321 0.046 DBMET00549 0.422 0.025 DBMET00563 | DBMET00563 | |
| 0.405 | 0.026 | 0.405 | Interleukin 2 agonist | 0.277 0.092 DBMET00549 | ||
| 0.372 | 0.006 | 0.372 | M18 aspartyl aminopeptidase inhibitor | 0.158 0.048 DBMET00549 0.124 0.068 DBMET00563 | ||
| 0.418 | 0.053 | 0.418 | Toll-Like receptor agonist | |||
| 0.364 | 0.003 | 0.364 | Adrenaline agonist | 0.176 0.009 DBMET00549 0.116 0.027 DBMET00563 | ||
| 0.412 | 0.055 | 0.412 | Toll-Like receptor 7 agonist | |||
| 0.39 | 0.037 | 0.516 | Antioxidant | 0.516 0.018 DBMET00549 0.492 0.021 DBMET00563 | DBMET00549 | |
| 0.355 | 0.002 | 0.355 | Adenylate cyclase stimulant | 0.343 0.002 DBMET00549 0.25 0.004 DBMET00563 | ||
| 0.399 | 0.049 | 0.625 | Antithrombotic | 0.566 0.02 DBMET00549 0.625 0.014 DBMET00563 | DBMET00563 | |
| 0.349 | 0.005 | 0.349 | Nitric-oxide synthase stimulant | 0.188 0.111 DBMET00549 0.199 0.09 DBMET00563 | ||
| 0.352 | 0.008 | 0.352 | Acetylcholine M1 receptor antagonist | 0.149 0.075 DBMET00549 | ||
| 0.34 | 0.014 | 0.34 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.182 0.09 DBMET00563 | ||
| 0.348 | 0.024 | 0.348 | Anesthetic general | |||
| 0.349 | 0.035 | 0.349 | Amyloid beta aggregation inhibitor | 0.139 0.117 DBMET00549 0.267 0.053 DBMET00563 | ||
| 0.318 | 0.005 | 0.318 | Histidine decarboxylase inhibitor | |||
| 0.374 | 0.073 | 0.374 | GABA C receptor rho-3 antagonist | |||
| 0.305 | 0.008 | 0.305 | Carbonic anhydrase XV inhibitor | 0.201 0.018 DBMET00549 0.186 0.021 DBMET00563 | ||
| 0.307 | 0.013 | 0.307 | Adenylate cyclase inhibitor | 0.127 0.062 DBMET00549 | ||
| 0.312 | 0.02 | 0.312 | Melanin inhibitor | 0.171 0.058 DBMET00563 | ||
| 0.305 | 0.018 | 0.305 | Amylase inhibitor | 0.204 0.043 DBMET00563 | ||
| 0.29 | 0.009 | 0.29 | Expectorant | 0.141 0.039 DBMET00549 0.206 0.019 DBMET00563 | ||
| 0.291 | 0.018 | 0.291 | Insulin sensitizer | 0.197 0.077 DBMET00549 0.232 0.046 DBMET00563 | ||
| 0.277 | 0.004 | 0.277 | HIV-1 integrase (Overall Integration) inhibitor | 0.203 0.011 DBMET00549 0.218 0.008 DBMET00563 | ||
| 0.291 | 0.019 | 0.479 | Monophenol monooxygenase inhibitor | 0.211 0.03 DBMET00549 0.479 0.008 DBMET00563 | DBMET00563 | |
| 0.289 | 0.019 | 0.452 | Phospholipase C inhibitor | 0.388 0.011 DBMET00549 0.452 0.008 DBMET00563 | DBMET00563 | |
| 0.316 | 0.048 | 0.316 | Hypoglycemic | 0.208 0.105 DBMET00563 | ||
| 0.269 | 0.005 | 0.269 | Mucolytic | 0.162 0.026 DBMET00549 0.201 0.013 DBMET00563 | ||
| 0.309 | 0.046 | 0.309 | Interleukin antagonist | |||
| 0.304 | 0.04 | 0.304 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.271 | 0.01 | 0.271 | Ferrochelatase inhibitor | |||
| 0.265 | 0.005 | 0.265 | Alpha adrenoreceptor agonist | |||
| 0.267 | 0.008 | 0.267 | Carbonic anhydrase III inhibitor | 0.238 0.011 DBMET00549 0.25 0.009 DBMET00563 | ||
| 0.327 | 0.071 | 0.422 | Immunostimulant | 0.403 0.048 DBMET00549 0.422 0.044 DBMET00563 | DBMET00563 | |
| 0.259 | 0.007 | 0.259 | Porphobilinogen synthase inhibitor | 0.113 0.03 DBMET00549 | ||
| 0.315 | 0.066 | 0.347 | Sodium/bile acid cotransporter inhibitor | 0.298 0.081 DBMET00549 0.347 0.042 DBMET00563 | DBMET00563 | |
| 0.252 | 0.003 | 0.252 | Beta 3 adrenoreceptor antagonist | 0.13 0.008 DBMET00549 0.099 0.015 DBMET00563 | ||
| 0.273 | 0.027 | 0.273 | Neurotrophic factor enhancer | 0.15 0.138 DBMET00563 | ||
| 0.267 | 0.022 | 0.267 | Protein kinase stimulant | |||
| 0.262 | 0.019 | 0.262 | Cholinergic antagonist | |||
| 0.246 | 0.003 | 0.246 | GABA B receptor agonist | 0.12 0.008 DBMET00549 0.107 0.012 DBMET00563 | ||
| 0.256 | 0.014 | 0.256 | Acetylcholine muscarinic antagonist | 0.103 0.087 DBMET00549 | ||
| 0.259 | 0.019 | 0.281 | Succinate dehydrogenase inhibitor | 0.179 0.069 DBMET00549 0.281 0.014 DBMET00563 | DBMET00563 | |
| 0.258 | 0.019 | 0.258 | Acetylcholine antagonist | |||
| 0.258 | 0.022 | 0.258 | Alpha-N-acetylglucosaminidase inhibitor | 0.11 0.088 DBMET00563 | ||
| 0.254 | 0.019 | 0.254 | Anesthetic local | |||
| 0.237 | 0.003 | 0.237 | Beta adrenoreceptor antagonist | 0.108 0.014 DBMET00549 0.08 0.027 DBMET00563 | ||
| 0.237 | 0.006 | 0.237 | Creatine kinase inhibitor | 0.139 0.029 DBMET00549 0.128 0.035 DBMET00563 | ||
| 0.293 | 0.063 | 0.293 | Insulysin inhibitor | |||
| 0.244 | 0.017 | 0.432 | Cell wall synthesis inhibitor | 0.432 0.005 DBMET00549 0.411 0.005 DBMET00563 | DBMET00549 | |
| 0.222 | 0.003 | 0.222 | Beta 2 adrenoreceptor antagonist | 0.09 0.009 DBMET00549 0.059 0.025 DBMET00563 | ||
| 0.22 | 0.002 | 0.22 | Alpha 2a adrenoreceptor agonist | 0.022 0.008 DBMET00549 | ||
| 0.235 | 0.017 | 0.235 | Cystathionine beta-synthase inhibitor | 0.106 0.07 DBMET00563 | ||
| 0.207 | 0.003 | 0.207 | Beta 1 adrenoreceptor antagonist | 0.086 0.015 DBMET00549 0.065 0.031 DBMET00563 | ||
| 0.206 | 0.009 | 0.206 | Dopamine agonist | 0.199 0.01 DBMET00549 | ||
| 0.26 | 0.065 | 0.51 | Angiogenesis stimulant | 0.51 0.011 DBMET00549 0.473 0.013 DBMET00563 | DBMET00549 | |
| 0.213 | 0.019 | 0.213 | Interleukin 4 antagonist | |||
| 0.212 | 0.019 | 0.212 | Toll-Like receptor 2 antagonist | 0.125 0.073 DBMET00563 | ||
| 0.208 | 0.016 | 0.208 | Cyclooxygenase 3 inhibitor | 0.142 0.055 DBMET00563 | ||
| 0.202 | 0.01 | 0.202 | Aminoacyl-tRNA synthetase inhibitor | 0.13 0.026 DBMET00549 | ||
| 0.204 | 0.013 | 0.229 | Carbonic anhydrase VI inhibitor | 0.168 0.017 DBMET00549 0.229 0.01 DBMET00563 | DBMET00563 | |
| 0.256 | 0.068 | 0.256 | Antiamyloidogenic | 0.192 0.105 DBMET00563 | ||
| 0.194 | 0.007 | 0.194 | Toll-Like receptor 3 antagonist | 0.095 0.059 DBMET00549 0.1 0.05 DBMET00563 | ||
| 0.19 | 0.005 | 0.19 | Alpha 2 adrenoreceptor agonist | |||
| 0.193 | 0.008 | 0.193 | Protein kinase B gamma inhibitor | |||
| 0.209 | 0.025 | 0.384 | Cholesterol synthesis inhibitor | 0.279 0.014 DBMET00549 0.384 0.005 DBMET00563 | DBMET00563 | |
| 0.197 | 0.013 | 0.197 | GABA C receptor antagonist | 0.135 0.039 DBMET00549 | ||
| 0.218 | 0.036 | 0.218 | MAO inhibitor | |||
| 0.189 | 0.008 | 0.189 | DOPA decarboxylase inhibitor | 0.093 0.092 DBMET00549 0.097 0.081 DBMET00563 | ||
| 0.251 | 0.074 | 0.251 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.246 | 0.069 | 0.246 | DNA synthesis inhibitor | 0.204 0.117 DBMET00563 | ||
| 0.189 | 0.012 | 0.189 | Sphingomyelinase inhibitor | 0.104 0.055 DBMET00563 | ||
| 0.255 | 0.083 | 0.255 | Transcription factor STAT inhibitor | |||
| 0.171 | 0.003 | 0.171 | Beta 2 adrenoreceptor agonist | 0.101 0.004 DBMET00549 0.077 0.011 DBMET00563 | ||
| 0.175 | 0.011 | 0.175 | Transcription factor STAT6 inhibitor | |||
| 0.176 | 0.014 | 0.176 | Urease inhibitor | 0.092 0.076 DBMET00549 0.094 0.074 DBMET00563 | ||
| 0.163 | 0.003 | 0.163 | Beta adrenoreceptor agonist | 0.068 0.005 DBMET00549 0.049 0.02 DBMET00563 | ||
| 0.176 | 0.019 | 0.176 | Adenylate kinase inhibitor | 0.108 0.056 DBMET00549 | ||
| 0.183 | 0.028 | 0.183 | Alpha 2b adrenoreceptor antagonist | |||
| 0.164 | 0.01 | 0.164 | Carbonic anhydrase stimulant | 0.065 0.035 DBMET00549 | ||
| 0.157 | 0.004 | 0.157 | Catechol O-methyltransferase inhibitor | 0.099 0.005 DBMET00549 0.035 0.019 DBMET00563 | ||
| 0.222 | 0.072 | 0.349 | RNA-directed DNA polymerase inhibitor | 0.297 0.032 DBMET00549 0.349 0.024 DBMET00563 | DBMET00563 | |
| 0.164 | 0.016 | 0.429 | Triose-phosphate isomerase inhibitor | 0.361 0.004 DBMET00549 0.429 0.003 DBMET00563 | DBMET00563 | |
| 0.161 | 0.013 | 0.174 | Anabolic | 0.174 0.009 DBMET00549 0.146 0.02 DBMET00563 | DBMET00549 | |
| 0.164 | 0.019 | 0.499 | Carbonic anhydrase XIII inhibitor | 0.499 0.003 DBMET00549 0.345 0.005 DBMET00563 | DBMET00549 | |
| 0.155 | 0.01 | 0.155 | Acetylcholine M3 receptor antagonist | |||
| 0.154 | 0.01 | 0.154 | Ornithine decarboxylase inhibitor | |||
| 0.174 | 0.031 | 0.235 | Antibacterial (Helicobacter pylori) | 0.138 0.058 DBMET00549 0.235 0.014 DBMET00563 | DBMET00563 | |
| 0.146 | 0.002 | 0.146 | Alpha 1d adrenoreceptor agonist | 0.055 0.013 DBMET00549 | ||
| 0.157 | 0.014 | 0.157 | Inducible nitric-oxide synthase inhibitor | 0.12 0.024 DBMET00549 | ||
| 0.15 | 0.009 | 0.15 | Alpha 1 adrenoreceptor agonist | |||
| 0.153 | 0.013 | 0.153 | Somatostatin 1 agonist | 0.092 0.04 DBMET00549 | ||
| 0.165 | 0.024 | 0.165 | Protein kinase C gamma inhibitor | |||
| 0.181 | 0.042 | 0.525 | Hemostatic | 0.525 0.004 DBMET00549 0.397 0.008 DBMET00563 | DBMET00549 | |
| 0.142 | 0.003 | 0.142 | Diamine oxidase inhibitor | |||
| 0.161 | 0.023 | 0.161 | Ca2+-transporting ATPase inhibitor | 0.139 0.077 DBMET00563 | ||
| 0.155 | 0.018 | 0.155 | Electron transport complex I inhibitor | 0.124 0.042 DBMET00563 | ||
| 0.149 | 0.012 | 0.149 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.14 | 0.003 | 0.14 | Dopamine D5 agonist | 0.042 0.025 DBMET00549 | ||
| 0.153 | 0.017 | 0.153 | NADH dehydrogenase inhibitor | 0.095 0.05 DBMET00549 0.11 0.035 DBMET00563 | ||
| 0.172 | 0.036 | 0.223 | Alkylator | 0.141 0.052 DBMET00549 0.223 0.02 DBMET00563 | DBMET00563 | |
| 0.15 | 0.014 | 0.15 | Keratolytic | 0.086 0.041 DBMET00563 | ||
| 0.167 | 0.031 | 0.198 | Aminopeptidase B inhibitor | 0.198 0.022 DBMET00549 0.16 0.034 DBMET00563 | DBMET00549 | |
| 0.15 | 0.016 | 0.15 | Glutamate dehydrogenase inhibitor | 0.081 0.044 DBMET00549 | ||
| 0.154 | 0.02 | 0.154 | GABA C receptor rho-1 antagonist | |||
| 0.185 | 0.051 | 0.227 | Phospholipase A2 inhibitor | 0.14 0.085 DBMET00549 0.227 0.031 DBMET00563 | DBMET00563 | |
| 0.142 | 0.009 | 0.142 | GABA aminotransferase inhibitor | |||
| 0.162 | 0.029 | 0.197 | Nav1.4 sodium channel blocker | 0.197 0.02 DBMET00549 0.106 0.067 DBMET00563 | DBMET00549 | |
| 0.135 | 0.003 | 0.135 | Alpha 1a adrenoreceptor agonist | 0.053 0.005 DBMET00549 | ||
| 0.183 | 0.051 | 0.187 | Arachidonic acid antagonist | 0.187 0.046 DBMET00563 | DBMET00563 | |
| 0.161 | 0.029 | 0.175 | Vanilloid 1 agonist | 0.138 0.052 DBMET00549 0.175 0.021 DBMET00563 | DBMET00563 | |
| 0.198 | 0.066 | 0.198 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.254 | 0.123 | 0.256 | Apoptosis antagonist | 0.256 0.121 DBMET00563 | DBMET00563 | |
| 0.193 | 0.062 | 0.193 | Growth hormone agonist | |||
| 0.152 | 0.021 | 0.152 | Nitric-oxide synthase inhibitor | 0.099 0.062 DBMET00549 | ||
| 0.137 | 0.007 | 0.137 | Maillard reaction inhibitor | |||
| 0.225 | 0.097 | 0.225 | DNA damaging | |||
| 0.159 | 0.033 | 0.159 | Chelator | |||
| 0.18 | 0.054 | 0.18 | Death-associated protein kinase 2 inhibitor | |||
| 0.166 | 0.041 | 0.166 | DNA polymerase I inhibitor | 0.115 0.072 DBMET00563 | ||
| 0.147 | 0.023 | 0.147 | Alpha 2a adrenoreceptor antagonist | |||
| 0.156 | 0.033 | 0.156 | Heat shock protein 70 antagonist | |||
| 0.192 | 0.07 | 0.24 | Hepatoprotectant | 0.24 0.046 DBMET00549 0.233 0.049 DBMET00563 | DBMET00549 | |
| 0.192 | 0.07 | 0.192 | Nitric oxide antagonist | 0.152 0.093 DBMET00549 0.18 0.076 DBMET00563 | ||
| 0.146 | 0.026 | 0.188 | NMDA receptor antagonist | 0.188 0.016 DBMET00549 0.081 0.064 DBMET00563 | DBMET00549 | |
| 0.15 | 0.031 | 0.15 | Photosensitizer | 0.1 0.089 DBMET00563 | ||
| 0.126 | 0.008 | 0.295 | Dopamine D2 agonist | 0.295 0.004 DBMET00549 | DBMET00549 | |
| 0.146 | 0.03 | 0.146 | UDP-glucose 4-epimerase inhibitor | |||
| 0.17 | 0.056 | 0.281 | Lipid peroxidase inhibitor | 0.165 0.059 DBMET00549 0.281 0.022 DBMET00563 | DBMET00563 | |
| 0.125 | 0.011 | 0.175 | Neuraminidase (influenza) inhibitor | 0.175 0.005 DBMET00549 0.13 0.01 DBMET00563 | DBMET00549 | |
| 0.17 | 0.057 | 0.17 | Interferon gamma antagonist | |||
| 0.139 | 0.026 | 0.139 | Protein kinase C delta inhibitor | |||
| 0.133 | 0.02 | 0.258 | NMDA 2 receptor antagonist | 0.258 0.006 DBMET00549 | DBMET00549 | |
| 0.213 | 0.101 | 0.213 | Calpain inhibitor | |||
| 0.14 | 0.03 | 0.14 | Alpha 2 adrenoreceptor antagonist | |||
| 0.226 | 0.117 | 0.323 | Lipoxygenase inhibitor | 0.323 0.06 DBMET00563 | DBMET00563 | |
| 0.136 | 0.029 | 0.136 | Prolactin inhibitor | |||
| 0.142 | 0.036 | 0.142 | Alpha 2c adrenoreceptor antagonist | |||
| 0.148 | 0.043 | 0.148 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.156 | 0.051 | 0.156 | NADPH oxidase inhibitor | |||
| 0.119 | 0.017 | 0.125 | Na+ K+ transporting ATPase inhibitor | 0.125 0.014 DBMET00549 0.125 0.014 DBMET00563 | DBMET00563 | |
| 0.168 | 0.066 | 0.168 | Neurotensin receptor agonist | |||
| 0.17 | 0.068 | 0.399 | Thrombolytic | 0.242 0.036 DBMET00549 0.399 0.011 DBMET00563 | DBMET00563 | |
| 0.205 | 0.104 | 0.26 | Tumour necrosis factor alpha release inhibitor | 0.26 0.07 DBMET00563 | DBMET00563 | |
| 0.114 | 0.014 | 0.114 | DNA gyrase inhibitor | |||
| 0.111 | 0.012 | 0.114 | NMDA 2C receptor antagonist | 0.114 0.012 DBMET00549 | DBMET00549 | |
| 0.15 | 0.052 | 0.15 | Pregnane X receptor agonist | |||
| 0.112 | 0.015 | 0.112 | Glycine receptor agonist | 0.069 0.058 DBMET00563 | ||
| 0.11 | 0.012 | 0.126 | Neuraminidase inhibitor | 0.126 0.009 DBMET00549 0.097 0.017 DBMET00563 | DBMET00549 | |
| 0.1 | 0.003 | 0.1 | Beta 1 adrenoreceptor agonist | 0.031 0.007 DBMET00549 | ||
| 0.111 | 0.014 | 0.111 | Estrogen-related receptor beta agonist | 0.086 0.05 DBMET00563 | ||
| 0.121 | 0.025 | 0.121 | Phosphofructokinase-1 inhibitor | 0.071 0.047 DBMET00563 | ||
| 0.111 | 0.019 | 0.111 | D-Ala-D-Ala ligase inhibitor | |||
| 0.204 | 0.113 | 0.204 | Neuropeptide Y2 antagonist | |||
| 0.097 | 0.006 | 0.237 | Mannosidase inhibitor | 0.141 0.004 DBMET00549 0.237 0.003 DBMET00563 | DBMET00563 | |
| 0.113 | 0.022 | 0.113 | Vanilloid agonist | 0.099 0.034 DBMET00549 0.113 0.022 DBMET00563 | ||
| 0.113 | 0.024 | 0.113 | Myeloperoxidase inhibitor | |||
| 0.103 | 0.017 | 0.103 | Acetylcholine M5 receptor antagonist | |||
| 0.093 | 0.007 | 0.142 | Phosphoglycerate kinase inhibitor | 0.099 0.007 DBMET00549 0.142 0.005 DBMET00563 | DBMET00563 | |
| 0.099 | 0.014 | 0.099 | MAP kinase kinase 7 inhibitor | |||
| 0.109 | 0.024 | 0.109 | Aminopeptidase I inhibitor | |||
| 0.131 | 0.047 | 0.131 | TRPA1 agonist | 0.118 0.061 DBMET00549 0.105 0.08 DBMET00563 | ||
| 0.094 | 0.011 | 0.143 | Factor IXa inhibitor | 0.143 0.004 DBMET00549 0.141 0.004 DBMET00563 | DBMET00549 | |
| 0.216 | 0.134 | 0.216 | 12-Lipoxygenase inhibitor | |||
| 0.111 | 0.029 | 0.111 | Glutamate release inhibitor | |||
| 0.298 | 0.217 | 0.543 | Antiinflammatory | 0.385 0.149 DBMET00549 0.543 0.071 DBMET00563 | DBMET00563 | |
| 0.091 | 0.01 | 0.091 | Sphingosine kinase 2 inhibitor | |||
| 0.089 | 0.008 | 0.258 | Alpha-mannosidase inhibitor | 0.113 0.005 DBMET00549 0.258 0.003 DBMET00563 | DBMET00563 | |
| 0.084 | 0.005 | 0.084 | Dopamine beta hydroxylase inhibitor | |||
| 0.099 | 0.021 | 0.099 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.115 | 0.036 | 0.115 | Glutamate (mGluR7) agonist | |||
| 0.086 | 0.008 | 0.086 | Dopamine D3 agonist | |||
| 0.122 | 0.046 | 0.122 | Mediator release inhibitor | |||
| 0.111 | 0.035 | 0.131 | Phosphodiesterase 6D inhibitor | 0.089 0.078 DBMET00549 0.131 0.017 DBMET00563 | DBMET00563 | |
| 0.091 | 0.016 | 0.091 | NMDA 2A receptor antagonist | 0.061 0.029 DBMET00549 | ||
| 0.111 | 0.035 | 0.327 | Catalase inhibitor | 0.156 0.025 DBMET00549 0.327 0.005 DBMET00563 | DBMET00563 | |
| 0.093 | 0.019 | 0.093 | Purinergic P2X1 antagonist | |||
| 0.114 | 0.043 | 0.114 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.092 | 0.021 | 0.092 | Biliverdin reductase inhibitor | |||
| 0.142 | 0.071 | 0.142 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.242 | 0.171 | 0.474 | 15-Lipoxygenase inhibitor | 0.474 0.047 DBMET00563 | DBMET00563 | |
| 0.125 | 0.055 | 0.125 | Microtubule formation inhibitor | 0.109 0.075 DBMET00563 | ||
| 0.14 | 0.069 | 0.14 | Neurotrophic factor | |||
| 0.088 | 0.019 | 0.169 | Carbonic anhydrase VB inhibitor | 0.162 0.008 DBMET00549 0.169 0.007 DBMET00563 | DBMET00563 | |
| 0.091 | 0.023 | 0.111 | NMDA receptor agonist | 0.111 0.015 DBMET00549 0.077 0.03 DBMET00563 | DBMET00549 | |
| 0.129 | 0.062 | 0.129 | Aldehyde dehydrogenase inhibitor | |||
| 0.157 | 0.09 | 0.157 | ATPase inhibitor | |||
| 0.101 | 0.034 | 0.101 | Granulocyte macrophage colony stimulating factor agonist | 0.084 0.065 DBMET00563 | ||
| 0.103 | 0.038 | 0.103 | Interleukin 5 antagonist | |||
| 0.199 | 0.135 | 0.199 | Transcription factor STAT3 inhibitor | |||
| 0.084 | 0.02 | 0.084 | Urokinase inhibitor | |||
| 0.084 | 0.021 | 0.084 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.092 | 0.03 | 0.301 | Carbonic anhydrase V inhibitor | 0.301 0.004 DBMET00549 0.194 0.008 DBMET00563 | DBMET00549 | |
| 0.227 | 0.166 | 0.227 | Calpain 2 inhibitor | |||
| 0.066 | 0.005 | 0.066 | Phenylethanolamine N methyltransferase inhibitor | 0.04 0.028 DBMET00549 | ||
| 0.099 | 0.039 | 0.099 | Glutathione S-transferase inhibitor | |||
| 0.096 | 0.037 | 0.096 | Macrophage migration inhibitory factor inhibitor | 0.085 0.045 DBMET00563 | ||
| 0.082 | 0.023 | 0.082 | Exportin-1 inhibitor | |||
| 0.105 | 0.047 | 0.105 | Alcohol dehydrogenase inhibitor | |||
| 0.081 | 0.023 | 0.081 | Glutamate (mGluR6) antagonist | |||
| 0.063 | 0.006 | 0.063 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.041 0.029 DBMET00549 0.038 0.037 DBMET00563 | ||
| 0.144 | 0.087 | 0.144 | CF transmembrane conductance regulator agonist | |||
| 0.089 | 0.032 | 0.151 | HIV-1 integrase inhibitor | 0.145 0.009 DBMET00549 0.151 0.008 DBMET00563 | DBMET00563 | |
| 0.06 | 0.003 | 0.06 | Beta 3 adrenoreceptor agonist | |||
| 0.073 | 0.017 | 0.073 | Aconitate hydratase inhibitor | |||
| 0.078 | 0.022 | 0.078 | Ornithine carbamoyltransferase inhibitor | |||
| 0.08 | 0.025 | 0.08 | Argininosuccinate synthase inhibitor | |||
| 0.286 | 0.232 | 0.286 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.097 | 0.043 | 0.097 | ATPase (Vacuolar H+) inhibitor | |||
| 0.1 | 0.046 | 0.1 | Histamine N-methyltransferase inhibitor | |||
| 0.101 | 0.048 | 0.144 | Bile acid receptor antagonist | 0.105 0.04 DBMET00549 0.144 0.009 DBMET00563 | DBMET00563 | |
| 0.094 | 0.043 | 0.094 | Acetylcholine nicotinic antagonist | |||
| 0.09 | 0.039 | 0.09 | Interferon agonist | 0.078 0.056 DBMET00549 0.079 0.054 DBMET00563 | ||
| 0.083 | 0.034 | 0.205 | Carbonic anhydrase VA inhibitor | 0.205 0.005 DBMET00549 0.139 0.013 DBMET00563 | DBMET00549 | |
| 0.072 | 0.023 | 0.085 | Sphingosine kinase inhibitor | 0.085 0.013 DBMET00549 0.06 0.039 DBMET00563 | DBMET00549 | |
| 0.081 | 0.033 | 0.338 | HIV-1 integrase (3'-Processing) inhibitor | 0.338 0.004 DBMET00549 0.217 0.009 DBMET00563 | DBMET00549 | |
| 0.082 | 0.034 | 0.082 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.083 | 0.035 | 0.083 | Amidase inhibitor | |||
| 0.106 | 0.059 | 0.106 | 5-Lipoxygenase inhibitor | |||
| 0.065 | 0.018 | 0.065 | Vanilloid 2 antagonist | 0.059 0.024 DBMET00549 0.063 0.019 DBMET00563 | ||
| 0.067 | 0.021 | 0.083 | Leukotriene B4 antagonist | 0.074 0.018 DBMET00549 0.083 0.014 DBMET00563 | DBMET00563 | |
| 0.22 | 0.176 | 0.455 | Immunosuppressant | 0.455 0.045 DBMET00563 | DBMET00563 | |
| 0.056 | 0.011 | 0.056 | Vascular adhesion protein 1 inhibitor | |||
| 0.073 | 0.029 | 0.073 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.059 | 0.015 | 0.059 | Somatostatin 1 antagonist | |||
| 0.086 | 0.044 | 0.086 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.073 | 0.031 | 0.073 | Interferon inducer | 0.065 0.042 DBMET00549 0.066 0.042 DBMET00563 | ||
| 0.057 | 0.017 | 0.057 | NMDA receptor subunit 3A antagonist | |||
| 0.056 | 0.016 | 0.056 | Neuraminidase (Influenza A) inhibitor | |||
| 0.059 | 0.02 | 0.059 | Alpha 1b adrenoreceptor agonist | |||
| 0.073 | 0.034 | 0.073 | Acetylcholine M2 receptor antagonist | |||
| 0.133 | 0.094 | 0.133 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.066 | 0.029 | 0.066 | Botulinum neurotoxin type A inhibitor | |||
| 0.049 | 0.013 | 0.049 | Glutamate (mGluR8) agonist | |||
| 0.096 | 0.06 | 0.096 | Alpha adrenoreceptor antagonist | |||
| 0.065 | 0.03 | 0.065 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.046 | 0.01 | 0.061 | Ceramide glucosyltransferase inhibitor | 0.041 0.016 DBMET00549 0.061 0.004 DBMET00563 | DBMET00563 | |
| 0.102 | 0.067 | 0.102 | Beta glucuronidase inhibitor | 0.098 0.073 DBMET00563 | ||
| 0.071 | 0.036 | 0.071 | 5 Hydroxytryptamine 2A agonist | |||
| 0.039 | 0.004 | 0.08 | 1,3-Beta-glucan synthase inhibitor | 0.08 0.002 DBMET00549 0.037 0.005 DBMET00563 | DBMET00549 | |
| 0.101 | 0.067 | 0.101 | Toll-Like receptor 4 antagonist | |||
| 0.057 | 0.023 | 0.057 | Squalene epoxidase inhibitor | |||
| 0.096 | 0.063 | 0.096 | Xanthine oxidase inhibitor | 0.091 0.07 DBMET00563 | ||
| 0.139 | 0.107 | 0.139 | Interleukin 6 antagonist | |||
| 0.078 | 0.045 | 0.18 | Cathepsin G inhibitor | 0.18 0.017 DBMET00549 0.079 0.044 DBMET00563 | DBMET00549 | |
| 0.043 | 0.011 | 0.043 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.073 | 0.041 | 0.271 | Selectin antagonist | 0.27 0.007 DBMET00549 0.271 0.007 DBMET00563 | DBMET00563 | |
| 0.109 | 0.077 | 0.109 | Estrogen antagonist | |||
| 0.039 | 0.008 | 0.039 | Purinergic P2Y15 antagonist | |||
| 0.046 | 0.015 | 0.046 | Somatostatin 5 antagonist | |||
| 0.056 | 0.025 | 0.056 | Topoisomerase II beta inhibitor | |||
| 0.072 | 0.042 | 0.072 | Protein kinase C alpha inhibitor | |||
| 0.055 | 0.025 | 0.055 | Factor III inhibitor | 0.047 0.042 DBMET00563 | ||
| 0.059 | 0.03 | 0.059 | Epithelial sodium channel blocker | |||
| 0.114 | 0.085 | 0.114 | DNA repair enzyme inhibitor | |||
| 0.098 | 0.069 | 0.098 | Estrogen receptor beta antagonist | |||
| 0.032 | 0.004 | 0.032 | Alpha 2b adrenoreceptor agonist | |||
| 0.146 | 0.118 | 0.146 | Pyruvate kinase inhibitor | |||
| 0.131 | 0.104 | 0.131 | GABA C receptor rho-2 antagonist | |||
| 0.046 | 0.019 | 0.046 | Kainate receptor agonist | |||
| 0.058 | 0.032 | 0.096 | Adenine nucleotide translocase inhibitor | 0.096 0.005 DBMET00549 0.084 0.007 DBMET00563 | DBMET00549 | |
| 0.051 | 0.024 | 0.051 | NMDA receptor subunit 3B antagonist | |||
| 0.054 | 0.029 | 0.054 | Carbonic anhydrase XIV inhibitor | 0.049 0.034 DBMET00563 | ||
| 0.046 | 0.02 | 0.046 | Heme oxygenase inhibitor | |||
| 0.044 | 0.019 | 0.044 | Arginase inhibitor | |||
| 0.031 | 0.006 | 0.031 | Factor IX inhibitor | |||
| 0.071 | 0.046 | 0.071 | Protein kinase C beta inhibitor | |||
| 0.058 | 0.033 | 0.368 | NMDA 2B receptor antagonist | 0.368 0.004 DBMET00549 0.188 0.006 DBMET00563 | DBMET00549 | |
| 0.058 | 0.033 | 0.058 | Dihydroorotate oxidase inhibitor | |||
| 0.052 | 0.027 | 0.052 | Glucose-6-phosphate isomerase inhibitor | 0.052 0.026 DBMET00563 | ||
| 0.037 | 0.013 | 0.037 | Uridine phosphorylase inhibitor | |||
| 0.059 | 0.035 | 0.059 | Protein kinase C eta inhibitor | |||
| 0.028 | 0.005 | 0.028 | Alpha 2c adrenoreceptor agonist | |||
| 0.054 | 0.03 | 0.054 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.067 | 0.043 | 0.067 | Leukotriene antagonist | 0.059 0.052 DBMET00563 | ||
| 0.125 | 0.103 | 0.125 | Insulin secretagoues | |||
| 0.046 | 0.024 | 0.046 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.033 | 0.011 | 0.033 | Estrogen-related receptor gamma antagonist | |||
| 0.122 | 0.1 | 0.127 | Farnesoid X receptor antagonist | 0.127 0.088 DBMET00563 | DBMET00563 | |
| 0.196 | 0.175 | 0.196 | Caspase 3 stimulant | |||
| 0.046 | 0.025 | 0.046 | Growth hormone release inhibitor | |||
| 0.039 | 0.019 | 0.039 | Fumarate hydratase inhibitor | |||
| 0.144 | 0.124 | 0.151 | Non-steroidal antiinflammatory agent | 0.151 0.113 DBMET00563 | DBMET00563 | |
| 0.094 | 0.074 | 0.132 | Gastric antisecretory | 0.112 0.05 DBMET00549 0.132 0.036 DBMET00563 | DBMET00563 | |
| 0.035 | 0.016 | 0.035 | Glutamate (mGluR3) agonist | |||
| 0.046 | 0.027 | 0.046 | Oxytocin agonist | |||
| 0.059 | 0.041 | 0.059 | Ryanodine receptor antagonist | |||
| 0.102 | 0.084 | 0.102 | Topoisomerase II inhibitor | |||
| 0.074 | 0.057 | 0.078 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.078 0.053 DBMET00563 | DBMET00563 | |
| 0.059 | 0.042 | 0.34 | HIV-1 integrase (Strand Transfer) inhibitor | 0.34 0.004 DBMET00549 0.212 0.009 DBMET00563 | DBMET00549 | |
| 0.029 | 0.012 | 0.029 | Vanilloid 2 agonist | 0.026 0.015 DBMET00549 | ||
| 0.057 | 0.04 | 0.057 | Pregnane X receptor antagonist | |||
| 0.08 | 0.064 | 0.08 | Histamine H2 receptor antagonist | |||
| 0.053 | 0.038 | 0.061 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.061 0.028 DBMET00563 | DBMET00563 | |
| 0.065 | 0.049 | 0.065 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.029 | 0.013 | 0.039 | Thyroid hormone agonist | 0.039 0.006 DBMET00549 | DBMET00549 | |
| 0.024 | 0.009 | 0.024 | Neuraminidase (Influenza B) inhibitor | |||
| 0.042 | 0.027 | 0.042 | Sphingosine kinase 1 inhibitor | |||
| 0.022 | 0.007 | 0.022 | Antibiotic Anthracycline-like | 0.021 0.01 DBMET00563 | ||
| 0.081 | 0.066 | 0.081 | mTOR complex 2 inhibitor | |||
| 0.087 | 0.074 | 0.087 | MAO A inhibitor | |||
| 0.026 | 0.012 | 0.053 | Dopamine D1 agonist | 0.053 0.004 DBMET00549 0.022 0.018 DBMET00563 | DBMET00549 | |
| 0.045 | 0.033 | 0.045 | Adenylate cyclase 1 inhibitor | |||
| 0.032 | 0.019 | 0.032 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.067 | 0.055 | 0.067 | Alpha 1b adrenoreceptor antagonist | |||
| 0.073 | 0.061 | 0.073 | Estrogen receptor alpha antagonist | |||
| 0.037 | 0.024 | 0.037 | Antibiotic Aminoglycoside-like | |||
| 0.053 | 0.041 | 0.053 | Glucosylceramidase inhibitor | |||
| 0.113 | 0.102 | 0.113 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.035 | 0.024 | 0.035 | Somatostatin 5 agonist | |||
| 0.039 | 0.028 | 0.039 | Membrane dipeptidase inhibitor | |||
| 0.019 | 0.011 | 0.019 | Estrogen-related receptor gamma agonist | |||
| 0.024 | 0.016 | 0.024 | Somatostatin 4 antagonist | |||
| 0.04 | 0.034 | 0.04 | Histamine H2 receptor agonist | |||
| 0.06 | 0.054 | 0.06 | Transcription factor RelA inhibitor | |||
| 0.026 | 0.02 | 0.026 | Lysine carboxypeptidase inhibitor | |||
| 0.054 | 0.048 | 0.054 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.013 | 0.007 | 0.013 | Glutamate (mGluR6) agonist | |||
| 0.037 | 0.032 | 0.037 | Toll-Like receptor 2 agonist | |||
| 0.058 | 0.053 | 0.108 | Purinergic P2X2 antagonist | 0.108 0.026 DBMET00563 | DBMET00563 | |
| 0.017 | 0.012 | 0.017 | Ileal bile acid transport inhibitor | |||
| 0.029 | 0.024 | 0.029 | Prostaglandin D2 agonist | |||
| 0.024 | 0.02 | 0.024 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.046 | 0.042 | 0.046 | Cytokine production stimulant | |||
| 0.068 | 0.064 | 0.092 | Topoisomerase II alpha inhibitor | 0.092 0.045 DBMET00563 | DBMET00563 | |
| 0.025 | 0.022 | 0.025 | Somatostatin 2 antagonist | |||
| 0.083 | 0.079 | 0.12 | Protein kinase C zeta inhibitor | 0.12 0.032 DBMET00549 0.11 0.04 DBMET00563 | DBMET00549 | |
| 0.021 | 0.018 | 0.021 | Prostaglandin F2 alpha agonist | |||
| 0.062 | 0.059 | 0.062 | Glutamate (mGluR7) antagonist | |||
| 0.067 | 0.064 | 0.067 | CYP2A6 inhibitor | |||
| 0.026 | 0.023 | 0.026 | Thrombin receptor antagonist | |||
| 0.04 | 0.037 | 0.04 | Geranyltranstransferase inhibitor | |||
| 0.103 | 0.101 | 0.103 | Cathepsin H inhibitor | |||
| 0.086 | 0.083 | 0.086 | Electrolyte absorption antagonist | |||
| 0.054 | 0.052 | 0.054 | Heat shock protein 90 beta antagonist | |||
| 0.071 | 0.07 | 0.071 | Protein kinase A inhibitor | |||
| 0.014 | 0.012 | 0.014 | Calcium-sensing receptor antagonist | |||
| 0.016 | 0.015 | 0.016 | Telomerase stimulant | |||
| 0.066 | 0.065 | 0.277 | CDC25A inhibitor | 0.186 0.008 DBMET00549 0.277 0.004 DBMET00563 | DBMET00563 | |
| 0.058 | 0.057 | 0.058 | Neuronal nicotinic receptor antagonist | |||
| 0.04 | 0.041 | 0.042 | Adenosine deaminase inhibitor | 0.042 0.038 DBMET00563 | DBMET00563 | |
| 0.045 | 0.049 | 0.063 | Alpha tubulin antagonist | 0.063 0.029 DBMET00563 | DBMET00563 | |
| 0.035 | 0.042 | 0.067 | Guanylate cyclase inhibitor | 0.067 0.006 DBMET00563 | DBMET00563 | |
| 0.025 | 0.034 | 0.03 | Cholesterol ester transfer protein antagonist | 0.03 0.024 DBMET00563 | DBMET00563 | |
| 0.034 | 0.044 | 0.079 | Phosphorylase inhibitor | 0.079 0.017 DBMET00563 | DBMET00563 | |
| 0.126 | 0.137 | 0.348 | Platelet adhesion inhibitor | 0.348 0.02 DBMET00549 0.297 0.035 DBMET00563 | DBMET00549 | |
| 0.131 | 0.144 | 0.186 | Antimitotic | 0.186 0.092 DBMET00549 0.149 0.122 DBMET00563 | DBMET00549 | |
| 0.054 | 0.068 | 0.058 | Trypsin inhibitor | 0.058 0.052 DBMET00549 | DBMET00549 | |
| 0.038 | 0.055 | 0.068 | Aldose reductase inhibitor | 0.068 0.028 DBMET00549 0.061 0.031 DBMET00563 | DBMET00549 | |
| 0.015 | 0.034 | 0.104 | Estrogen receptor beta agonist | 0.104 0.011 DBMET00549 0.033 0.023 DBMET00563 | DBMET00549 | |
| 0.046 | 0.065 | 0.057 | Androgen agonist | 0.057 0.045 DBMET00563 | DBMET00563 | |
| 0.091 | 0.111 | 0.151 | Acetylcholine release stimulant | 0.113 0.06 DBMET00549 0.151 0.016 DBMET00563 | DBMET00563 | |
| 0.136 | 0.161 | 0.173 | Platelet antagonist | 0.173 0.123 DBMET00549 | DBMET00549 | |
| 0.198 | 0.223 | 0.285 | Alpha-glucosidase inhibitor | 0.285 0.168 DBMET00563 | DBMET00563 | |
| 0.029 | 0.058 | 0.171 | Estrogen agonist | 0.171 0.01 DBMET00549 0.092 0.019 DBMET00563 | DBMET00549 | |
| 0.013 | 0.043 | 0.025 | Glutamate (mGluR1a) agonist | 0.022 0.015 DBMET00549 0.025 0.012 DBMET00563 | DBMET00563 | |
| 0.046 | 0.089 | 0.091 | Antineoplastic antibiotic | 0.091 0.051 DBMET00563 | DBMET00563 | |
| 0.028 | 0.074 | 0.046 | Plasmin inhibitor | 0.046 0.034 DBMET00549 | DBMET00549 | |
| 0.088 | 0.14 | 0.258 | Alkaline phosphatase inhibitor | 0.128 0.078 DBMET00549 0.258 0.018 DBMET00563 | DBMET00563 | |
| 0.028 | 0.082 | 0.055 | Beta tubulin antagonist | 0.055 0.043 DBMET00563 | DBMET00563 | |
| 0.049 | 0.107 | 0.071 | Phospholipase D inhibitor | 0.071 0.051 DBMET00563 | DBMET00563 | |
| 0.093 | 0.154 | 0.309 | Diuretic | 0.309 0.021 DBMET00549 0.215 0.039 DBMET00563 | DBMET00549 | |
| 0.076 | 0.138 | 0.153 | Tubulin antagonist | 0.153 0.056 DBMET00563 | DBMET00563 | |
| 0.104 | 0.173 | 0.584 | Dual specificity phosphatase inhibitor | 0.386 0.016 DBMET00549 0.584 0.005 DBMET00563 | DBMET00563 | |
| 0.052 | 0.125 | 0.087 | Glycine receptor antagonist | 0.087 0.047 DBMET00549 0.074 0.067 DBMET00563 | DBMET00549 | |
| 0.051 | 0.126 | 0.071 | Phosphodiesterase VI inhibitor | 0.071 0.06 DBMET00563 | DBMET00563 | |
| 0.197 | 0.278 | 0.322 | Apoptosis agonist | 0.322 0.157 DBMET00563 | DBMET00563 | |
| 0.085 | 0.171 | 0.543 | Anticoagulant | 0.543 0.008 DBMET00549 0.455 0.013 DBMET00563 | DBMET00549 | |
| 0.039 | 0.139 | 0.118 | Thrombin inhibitor | 0.118 0.018 DBMET00549 | DBMET00549 | |
| 0.081 | 0.186 | 0.359 | Protein-tyrosine phosphatase inhibitor | 0.32 0.016 DBMET00549 0.359 0.011 DBMET00563 | DBMET00563 | |
| 0.044 | 0.168 | 0.2 | Protein-tyrosine phosphatase 1B inhibitor | 0.185 0.033 DBMET00549 0.2 0.029 DBMET00563 | DBMET00563 | |
| 0.016 | 0.145 | 0.087 | Carbonic anhydrase inhibitor | 0.087 0.032 DBMET00549 | DBMET00549 | |
| 0.028 | 0.158 | 0.076 | Heparanase inhibitor | 0.051 0.042 DBMET00549 0.076 0.008 DBMET00563 | DBMET00563 | |
| 0.011 | 0.144 | 0.084 | NMDA 2D receptor antagonist | 0.084 0.004 DBMET00549 0.047 0.008 DBMET00563 | DBMET00549 | |
| 0.011 | 0.146 | 0.078 | Factor Xa inhibitor | 0.078 0.018 DBMET00549 | DBMET00549 | |
| 0.017 | 0.164 | 0.671 | Cholecystokinin B agonist | 0.671 0.001 DBMET00549 0.266 0.004 DBMET00563 | DBMET00549 | |
| 0.009 | 0.168 | 0.035 | Farnesoid X receptor agonist | 0.035 0.029 DBMET00563 | DBMET00563 | |
| 0.004 | 0.167 | 0.074 | Estrone sulfatase inhibitor | 0.074 0.005 DBMET00549 0.028 0.011 DBMET00563 | DBMET00549 | |
| 0.013 | 0.208 | 0.057 | Leukocyte elastase inhibitor | 0.057 0.019 DBMET00549 0.043 0.029 DBMET00563 | DBMET00549 | |
| 0.051 | 0.298 | 0.573 | Dual specificity phosphatase 3 inhibitor | 0.343 0.022 DBMET00549 0.573 0.005 DBMET00563 | DBMET00563 | |
| 0.028 | 0.381 | 0.209 | Multidrug resistance-associated protein 1 inhibitor | 0.209 0.009 DBMET00549 0.164 0.019 DBMET00563 | DBMET00549 | |
| 0.028 | 0.394 | 0.12 | Breast cancer-resistant protein inhibitor | 0.12 0.04 DBMET00563 | DBMET00563 | |
| 0.056 | 0.47 | 0.432 | Angiogenesis inhibitor | 0.409 0.051 DBMET00549 0.432 0.044 DBMET00563 | DBMET00563 | |
| 0.004 | 0.421 | 0.68 | Cholecystokinin agonist | 0.68 0.002 DBMET00549 0.15 0.004 DBMET00563 | DBMET00549 | |
| 0.011 | 0.438 | 0.038 | Purinergic P2Y2 antagonist | 0.034 0.022 DBMET00549 0.038 0.018 DBMET00563 | DBMET00563 | |
| 0.004 | 0.436 | 0.601 | Cholecystokinin A agonist | 0.601 0.002 DBMET00549 0.139 0.003 DBMET00563 | DBMET00549 | |
| 0.011 | 0.458 | 0.036 | Toll-Like receptor 4 agonist | 0.028 0.014 DBMET00549 0.036 0.006 DBMET00563 | DBMET00563 | |
| 0.003 | 0.539 | 0.29 | Cholecystokinin A antagonist | 0.29 0.004 DBMET00549 0.039 0.025 DBMET00563 | DBMET00549 | |
| 0.003 | 0.541 | 0.206 | Cholecystokinin B antagonist | 0.206 0.004 DBMET00549 | DBMET00549 | |
| 0.004 | 0.552 | 0.23 | Cholecystokinin antagonist | 0.23 0.004 DBMET00549 | DBMET00549 | |
| 0.037 | 0.665 | 0.293 | Immunomodulator | 0.293 0.086 DBMET00563 | DBMET00563 | |
| 0.006 | 0.638 | 0.093 | Elastase inhibitor | 0.093 0.012 DBMET00549 | DBMET00549 | |
| 0.003 | 0.672 | 0.04 | Factor XI inhibitor | 0.04 0.016 DBMET00549 | DBMET00549 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |